COVID-19 pill could be available later this year: Pfizer CEO

COVID-19 pill could be available later this year: pfizer CEO

(HealthDay)—A pill to treat COVID-19 is being developed by Pfizer and could be available by the end of the year, company CEO Albert Bourla says.

In March, Pfizer launched an early-stage clinical trial of a new antiviral drug for the coronavirus that causes COVID-19, CBS News reported. The drug reduces the production of enzymes the virus needs to multiply in human cells.

If are successful and the U.S. Food and Drug Administration approves the drug, it could be available across the United States later in 2021, Bourla told CNBC on Tuesday, CBS News reported.

Last month, Mikael Dolsten, M.D., chief scientific officer and president, worldwide research, development, and medical of Pfizer, said it is possible that the new drug could be prescribed "at the first sign of infection, without requiring that patients are hospitalized or in critical care."


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: CBS News Article

Copyright © 2021 HealthDay. All rights reserved.

Citation: COVID-19 pill could be available later this year: Pfizer CEO (2021, April 30) retrieved 7 May 2021 from https://medicalxpress.com/news/2021-04-covid-pill-year-pfizer-ceo.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
46 shares

Feedback to editors

User comments